ZJAMP Group Co., Ltd. (002758.SZ)
CNY 9.38
(-1.99%)
CNY 9.38
(-1.99%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 12.99 Billion CNY | 0.45% |
| 2022 | 12.93 Billion CNY | 24.36% |
| 2021 | 10.4 Billion CNY | 36.97% |
| 2020 | 7.59 Billion CNY | 750.6% |
| 2019 | 892.78 Million CNY | 2.26% |
| 2018 | 873.01 Million CNY | 37.73% |
| 2017 | 633.84 Million CNY | 25.66% |
| 2016 | 504.39 Million CNY | 23.41% |
| 2015 | 408.71 Million CNY | -14.46% |
| 2014 | 477.81 Million CNY | -4.04% |
| 2013 | 497.95 Million CNY | 13.62% |
| 2012 | 438.24 Million CNY | 17.89% |
| 2011 | 371.72 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 11.14 Billion CNY | -10.51% |
| 2024 Q1 | 12.83 Billion CNY | -1.21% |
| 2024 Q2 | 12.44 Billion CNY | -3.02% |
| 2023 Q2 | 11.1 Billion CNY | -5.0% |
| 2023 Q4 | 12.99 Billion CNY | -3.25% |
| 2023 FY | 12.99 Billion CNY | 0.45% |
| 2023 Q1 | 11.68 Billion CNY | -9.67% |
| 2023 Q3 | 13.43 Billion CNY | 20.98% |
| 2022 FY | 12.93 Billion CNY | 24.36% |
| 2022 Q3 | 12.3 Billion CNY | -8.01% |
| 2022 Q1 | 11.73 Billion CNY | 12.81% |
| 2022 Q4 | 12.93 Billion CNY | 5.13% |
| 2022 Q2 | 13.37 Billion CNY | 13.98% |
| 2021 Q2 | 8.65 Billion CNY | 1.76% |
| 2021 FY | 10.4 Billion CNY | 36.97% |
| 2021 Q3 | 8.63 Billion CNY | -0.17% |
| 2021 Q1 | 8.5 Billion CNY | 11.98% |
| 2021 Q4 | 10.4 Billion CNY | 20.41% |
| 2020 Q4 | 7.59 Billion CNY | 895.53% |
| 2020 Q1 | 833.12 Million CNY | -6.68% |
| 2020 FY | 7.59 Billion CNY | 750.6% |
| 2020 Q2 | 764.41 Million CNY | -8.25% |
| 2020 Q3 | 762.81 Million CNY | -0.21% |
| 2019 Q3 | 880.97 Million CNY | 1.2% |
| 2019 FY | 892.78 Million CNY | 2.26% |
| 2019 Q4 | 892.78 Million CNY | 1.34% |
| 2019 Q2 | 870.51 Million CNY | -0.58% |
| 2019 Q1 | 875.57 Million CNY | 0.29% |
| 2018 FY | 873.01 Million CNY | 37.73% |
| 2018 Q4 | 873.01 Million CNY | 7.1% |
| 2018 Q1 | 643.82 Million CNY | 1.57% |
| 2018 Q2 | 768.98 Million CNY | 19.44% |
| 2018 Q3 | 815.13 Million CNY | 6.0% |
| 2017 Q3 | 586.4 Million CNY | -0.15% |
| 2017 Q4 | 633.84 Million CNY | 8.09% |
| 2017 FY | 633.84 Million CNY | 25.66% |
| 2017 Q2 | 587.27 Million CNY | 12.4% |
| 2017 Q1 | 522.47 Million CNY | 3.58% |
| 2016 Q1 | 363.64 Million CNY | -11.03% |
| 2016 Q4 | 504.39 Million CNY | 18.51% |
| 2016 Q3 | 425.62 Million CNY | 9.07% |
| 2016 Q2 | 390.22 Million CNY | 7.31% |
| 2016 FY | 504.39 Million CNY | 23.41% |
| 2015 FY | 408.71 Million CNY | -14.46% |
| 2015 Q4 | 408.71 Million CNY | 11.16% |
| 2015 Q3 | 367.69 Million CNY | -10.52% |
| 2015 Q2 | 410.9 Million CNY | -2.85% |
| 2015 Q1 | 422.97 Million CNY | -11.48% |
| 2014 Q4 | 477.81 Million CNY | 0.0% |
| 2014 FY | 477.81 Million CNY | -4.04% |
| 2013 FY | 497.95 Million CNY | 13.62% |
| 2012 FY | 438.24 Million CNY | 17.89% |
| 2011 FY | 371.72 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 11.02 Billion CNY | -17.81% |
| Yixintang Pharmaceutical Group Co., Ltd. | 8.75 Billion CNY | -48.379% |
| Luyan Pharma Co.,Ltd. | 8.81 Billion CNY | -47.376% |
| Ji Yao Holding Group Co., Ltd. | 2.72 Billion CNY | -377.543% |